OPAVIRALINE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C14H17FN2O3
Molecular Weight	280.2948
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC[C@@H]1N(C(=O)OC(C)C)C2=C(NC1=O)C=CC(F)=C2

InChI

InChIKey=KELNNWMENBUHNS-NSHDSACASA-N

InChI=1S/C14H17FN2O3/c1-4-11-13(18)16-10-6-5-9(15)7-12(10)17(11)14(19)20-8(2)3/h5-8,11H,4H2,1-3H3,(H,16,18)/t11-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C14H17FN2O3
Molecular Weight	280.2948
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://adisinsight.springer.com/drugs/800011603 | https://www.ncbi.nlm.nih.gov/pubmed/10846052

Opaviraline (also known as GW 420867), a nonnucleoside reverse transcriptase inhibitor that was studied for the treatment of HIV infections. The drug participated in clinical trials phase II in Germany, in South Africa, and in the United Kingdom, however, these studies were discontinued.

Originator

Approval Year

PubMed

Title	Date	PubMed
The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.	2005 Apr 25	15848161
Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.	2006 Aug	16616962

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:30:38 GMT 2023` Edited by `admin` on `Fri Dec 15 16:30:38 GMT 2023`
Record UNII	Q3A8EU2NMU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OPAVIRALINE

Official Name

English

HBY-1293

Code

English

GW-420867

Code

English

opaviraline [INN]

Common Name

English

ISOPROPYL (S)-2-ETHYL-7-FLUORO-3,4-DIHYDRO-3-OXO-1(2H)-QUINOXALINECARBOXYLATE

Systematic Name

English

GW-420867X

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C97453